Synthetic gene circuits in tumor immunotherapy: design principles and applications
Current Opinion in Biotechnology · 2026-08 · 100 · 103517
DOI: 10.1016/j.copbio.2026.103517 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2026-08. Verfasst von Jinzhong Tian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regula…. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Gene Regulatory Networks, Genes, Synthetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, National Key Research and Development Program of China.
Abstract (Originalsprache)
Tumor immunotherapy has revolutionized cancer treatment by harnessing the immune system to recognize and eliminate malignant cells. However, limited response rates, systemic toxicity, and tumor heterogeneity remain major challenges. Synthetic gene circuits - engineered genetic programs capable of sensing, integrating, and responding to biological cues - offer a powerful strategy for developing next-generation 'smart' therapeutics. In this review, we summarize recent advances in synthetic gene circuits that enable smart and controllable tumor immunotherapy. We then discuss the design principles of these circuits, including small-molecule-inducible, physically responsive, and endogenous signal-responsive systems. Representative applications in tumor immunotherapy are highlighted, including programmable immune cells, microbial platforms, and tumor-intrinsic circuits that enable context-dependent activation, localized cytokine or effector release, and tumor-selective immunogenic cell death. Collectively, these advances illustrate the potential of synthetic gene circuits to improve specificity, safety, and therapeutic efficacy, paving the way for precision cancer immunotherapy and the next generation of cancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Scie…
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- National Key Research and Development Program of China
Zitieren
APA
Tian, J., Wang, Z., & Ye, H. (2026). Synthetic gene circuits in tumor immunotherapy: design principles and applications. Current Opinion in Biotechnology, 100, 103517. https://doi.org/10.1016/j.copbio.2026.103517
Vancouver
Tian J, Wang Z, Ye H. Synthetic gene circuits in tumor immunotherapy: design principles and applications. Current Opinion in Biotechnology. 2026;100:103517. doi:10.1016/j.copbio.2026.103517
BibTeX
@article{Tian2026,
author = {Tian, Jinzhong and Wang, Zhihao and Ye, Haifeng},
title = {Synthetic gene circuits in tumor immunotherapy: design principles and applications},
journal = {Current Opinion in Biotechnology},
year = {2026},
volume = {100},
pages = {103517},
doi = {10.1016/j.copbio.2026.103517}
}
EUVIMED